Sartorius AG (SATG)

Currency in EUR
177.00
-0.40(-0.23%)
Closed·
SATG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
176.20181.80
52 wk Range
145.40208.00
Key Statistics
Bid/Ask
176.00 / 177.00
Prev. Close
177.4
Open
179.2
Day's Range
176.2-181.8
52 wk Range
145.4-208
Volume
1.42K
Average Volume (3m)
4.07K
1-Year Change
11.0414%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SATG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
249.53
Upside
+40.98%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Sartorius AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 249.53
(+40.98% Upside)

Earnings

Latest Release
Jul 23, 2026
EPS / Forecast
1.29 / 1.36
Revenue / Forecast
911.8M / 933.23M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
0.41%
Industry Median 2.02%
Annualised payout
0.73
Paid annually
5-Years Growth
+1.12%
Growth Streak

SATG Income Statement

Compare SATG to Peers and Sector

Metrics to compare
SATG
Peers
Sector
Relationship
P/E Ratio
71.6x26.5x−0.3x
PEG Ratio
-−0.170.00
Price/Book
5.0x2.1x2.6x
Price / LTM Sales
3.9x3.0x2.9x
Upside (Analyst Target)
37.4%7.7%56.7%
Fair Value Upside
Unlock4.3%10.2%Unlock

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Employees
14279
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.83M15.68%1.92B
Other Institutional Investors
41.87M60.64%7.43B
Public Companies & Retail Investors
16.35M23.68%2.90B
Total
69.04M100.00%12.25B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bio-Rad Laboratories, Inc.32.97%22,758,5084,037,359
Estate of Horst Sartorius27.28%18,831,2683,340,667

FAQ

What Is the Sartorius (SATG) Stock Price Today?

The Sartorius stock price today is 177.00 EUR.

What Stock Exchange Does Sartorius Trade On?

Sartorius is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Sartorius?

The stock symbol for Sartorius is "SATG."

What Is the Sartorius Market Cap?

As of today, Sartorius market cap is 12.26B EUR.

When Is the Next Sartorius Earnings Date?

Sartorius will release its next earnings report on Oct 22, 2026.

From a Technical Analysis Perspective, Is SATG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sartorius Stock Split?

Sartorius has split 1 times.

How Many Employees Does Sartorius Have?

Sartorius has 14279 employees.

What is the current trading status of Sartorius (SATG)?

As of Jul 30, 2026, Sartorius (SATG) is trading at a price of 177.00 EUR, with a previous close of 177.40 EUR. The stock has fluctuated within a day range of 176.20 EUR to 181.80 EUR, while its 52-week range spans from 145.40 EUR to 208.00 EUR.

What Is Sartorius (SATG) Price Target According to Analysts?

The average 12-month price target for Sartorius is 249.53 EUR, with a high estimate of 445 EUR and a low estimate of 68.75 EUR. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +40.98% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.